Prostate News Archive
12-Nov-2006
Study First: Over-expression Of Cox-2 Can Predict Prostate Cancer Outcome (Medical News Today)
Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate. That is the result of the first study linking COX-2 (cyclooxygenase-2) with prostate cancer radiation treatment outcomes. [click link for full article] Largest PSA Bounce Study Eases Worry Of Prostate Cancer Returning (Medical News Today)
prostate cancer patients who have a temporary rise in their prostate specific antigen (PSA) levels after radiation therapy - called a PSA bounce - are not at an increased risk of their cancer coming back any more than those who don't have a temporary rise, according to the largest study of its kind p [click link for full article] New Classification Better Identifies Prostate Cancer Patients To Benefit From Hormone Therapy (Medical News Today)
A new classification system for evaluating men after radiation treatment for prostate cancer better determines which men may recur and thus may benefit from hormone therapy. The results of a study applying the new system were presented 8-Nov-2006 at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Philadelphia. [click link for full article] Prostate Cancer Less Likely To Spread When Treated With Higher Dose Of Radiation (Medical News Today)
New research suggests that men with prostate cancer who choose radiation therapy should seek treatment centers that will offer high-dose radiation. A new study from Fox Chase Cancer Center finds that higher doses of 74 to 82 Gray (Gy) greatly reduce the risk that the cancer will spread later--even 8-10 years after treatment. [click link for full article]
Back to Prostate News Archive
